相关实验视频
Updated: Jun 5, 2025

07:37
Roux-en-Y Gastric Bypass Operation in Rats
Published on: June 11, 2012
23.5K
新的神经通路是GLP-1R激动剂和减肥手术的目标
Mohammed K Hankir1,2, Thomas A Lutz3
1Institute of Veterinary Physiology, University of Zurich, Zurich, Switzerland.
Pflugers Archiv : European journal of physiology
|December 7, 2024
概括
葡萄糖类1受体 (GLP-1R) 激动剂和减肥手术都通过向大脑来降低肥胖. 了解它们的神经通路可能会改善减肥治疗.
科学领域:
- 神经科学是一个神经科学.
- 内分泌学 在内分泌学.
- 减肥医学 减肥医学
背景情况:
- 类似葡萄糖类1受体 (GLP-1R) 激动剂,如塞马格卢提德,提供了新的肥胖治疗方法.
- 减肥手术是严重肥胖症的经过验证的长期解决方案.
- 这两种干预措施都通过作用于大脑来抑制食欲,尽管机制尚未完全理解.
研究的目的:
- 审查最近关于神经控制食物摄入量和体重的临床前研究.
- 探索内源GLP-1,GLP-1R激动剂和减肥手术在体重调节中的作用.
- 阐明这些干预措施如何准大脑的共同点和差异.
主要方法:
- 审查当代神经科学技术和临床前研究.
- 追踪神经通路从外围 (阴道,肠,脊髓神经) 到大脑干,下丘脑和非正规的养中心 (不确定的区域,侧面隔膜).
主要成果:
- GLP-1R激动剂和减肥手术汇聚在控制食物摄入量和体重的神经通路上.
- 有证据表明,这些干预措施调节了从肠道到大脑的食欲信号.
- 特定的大脑区域,包括下丘脑和不确定的区域,都与他们的影响有关.
结论:
- 识别GLP-1R激动剂和减肥手术的共享和独特的神经点,可以弥合药理和手术的方法.
- 了解这些神经机制可能会为增强减肥的联合治疗策略提供信息.
- 这一综述为优化肥胖干预提供了一个神经基础.
相关概念视频
Glucagon-like Receptor Agonists
298
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
298
Regulation of Food Intake
187
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
187
Neural Regulation
39.1K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.1K
Oral Hypoglycemic Agents: Glinides
139
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
139
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.1K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.1K
Dipeptidyl Peptidase 4 Inhibitors
171
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
171

